Home

Novavax, Inc. - Common Stock (NVAX)

7.2000
-0.2100 (-2.83%)
NASDAQ · Last Trade: Jun 10th, 5:37 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidancebenzinga.com
The American Pharmacists Association announced Monday it will withhold endorsement of the CDC's updated immunization schedule.
Via Benzinga · June 10, 2025
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?stocktwits.com
Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he called a "crisis of public trust."
Via Stocktwits · June 10, 2025
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.investors.com
A CDC committee in charge of making vaccine recommendations was gutted Monday to make way for a new coalition.
Via Investor's Business Daily · June 9, 2025
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Expertsbenzinga.com
U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health experts call a dichotomy in his approach to healthcare policy.
Via Benzinga · June 6, 2025
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individualsbenzinga.com
Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved efficacy and safety profile.
Via Benzinga · June 2, 2025
RFK Jr. Drops COVID Vaccine Recommendation For Healthy Kids, But Experts Warn Of Major Risksbenzinga.com
The U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced the Centers for Disease Control and Prevention will no longer recommend COVID-19 vaccines for healthy children and pregnant women, sparking criticism from public health experts who cite ongoing risks.
Via Benzinga · May 30, 2025
Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effortbenzinga.com
The Trump administration terminated a nearly $600 million award to Moderna for developing an mRNA-based bird flu vaccine, ending a key Biden-era pandemic preparedness initiative. The cancellation introduces uncertainty into the nation's defense strategy against H5N1 avian influenza despite positive clinical trial results.
Via Benzinga · May 29, 2025
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Childrenbenzinga.com
RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though the official site still shows it listed.
Via Benzinga · May 27, 2025
Analysts Think These Stocks Could More Than Double in Value
Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.
Via MarketBeat · May 23, 2025
What's Driving the Market Sentiment Around Novavax?benzinga.com
Via Benzinga · May 21, 2025
FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.benzinga.com
The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults.
Via Benzinga · May 21, 2025
FDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks Risestocktwits.com
The agency plans to demand stronger evidence of efficacy for the shots before approval is granted for healthy persons, between the ages of six months and 64 years, with no risk factors for severe COVID-19 infection.
Via Stocktwits · May 20, 2025
The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.investors.com
The new framework limits future Covid shots to people age 65 and older and those six months and older with a risk factor for serious illness.
Via Investor's Business Daily · May 20, 2025
US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expertbenzinga.com
U.S. stock futures were slightly lower on Tuesday after ending largely flat on Monday. Futures of major benchmark indices were trading lower in premarket.
Via Benzinga · May 20, 2025
Dow Surges Over 100 Points Despite Moody's US Downgrade: Fear Index Remains In 'Greed' Zonebenzinga.com
Via Benzinga · May 20, 2025
Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday?benzinga.com
U.S. stocks trimmed early-session losses by midday Monday, as investors showed limited concern after Moody's downgraded U.S. sovereign credit from Aaa to Aa1, effectively stripping the world's largest economy of its last top-tier credit rating.
Via Benzinga · May 19, 2025
Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higherbenzinga.com
Via Benzinga · May 19, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · May 19, 2025
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Paymentbenzinga.com
Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.
Via Benzinga · May 19, 2025
Gapping stocks in Monday's sessionchartmill.com
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · May 19, 2025
CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · May 19, 2025
Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovidstocktwits.com
Novavax CEO John C. Jacobs called the approval a “significant milestone” as the company seeks to make its protein-based COVID-19 vaccine commercially available.
Via Stocktwits · May 19, 2025
These stocks are moving in today's pre-market sessionchartmill.com
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · May 19, 2025
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · May 19, 2025
US Stocks Likely To Open Lower After Moody's Downgrade: 'Bear Market Isn't Fully Recovered Yet, But It Is Close,' Says Expertbenzinga.com
U.S. stock futures dipped on Monday after closing higher for the day and the week on Friday. Futures were trading lower in premarket.
Via Benzinga · May 19, 2025